This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Community Health Q2 Earnings Miss on Declining Patient Days
by Zacks Equity Research
CYH posts Q2 loss despite revenue beat, as patient days and adjusted admissions decline year over year.
Community Health Systems (CYH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of -200.00% and +3.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights HCA Healthcare, Tenet Healthcare, Universal Health and Community Health Systems
by Zacks Equity Research
Despite industry pressures, HCA, THC, UHS, and CYH are leveraging M&A, tech, and rising demand to drive resilient growth.
Hospital Market May Be Sick, But These 4 Stocks Are Healthy
by Kaibalya Pravo Dey
HCA, THC, UHS, and CYH are showing strength through smart expansions and solid earnings despite hospital industry headwinds.
Community Health Systems (CYH) Up 29.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Community Health Q1 Earnings Top on Rising Patient Volumes, Stock Up 8%
by Zacks Equity Research
CYH continues to witness growth in same-store admissions in the first quarter. Net loss per share is expected between 55 cents and breakeven in 2025.
Zacks Industry Outlook Highlights HCA Healthcare, Tenet Healthcare, Universal Health Services and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Tenet Healthcare, Universal Health Services and Community Health Systems have been highlighted in this Industry Outlook article.
Doctor's Orders: 4 Hospital Stocks to Benefit From Industry Trends
by Kaibalya Pravo Dey
The Zacks Medical-Hospital industry is likely to gain from growing demand, improving operating stability and finances. Companies like HCA, THC, UHS and CYH are poised to benefit from these trends.
Compared to Estimates, Community Health Systems (CYH) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Community Health Systems (CYH) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Community Health Systems (CYH) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 70% and 1.44%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Universal Health Services (UHS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CYH to Sell Stake in Cedar Park Regional to Ascension in $460M Deal
by Zacks Equity Research
Community Health is set to divest an 80% ownership stake in Cedar Park Regional to Ascension Health.
Community Health Systems (CYH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Community Health Systems (CYH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Community Health Rides on Same-Store Volumes, Streamlining Efforts
by Zacks Equity Research
With improving labor trends, CYH's contract labor expenses are decreasing.
Community Health Systems (CYH) Down 24.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Community Health's Florida Divestiture Matters
by Zacks Equity Research
Offloading the Punta Gorda facility is expected to remove uncertainty tied to restoration costs and revenue losses for CYH.
Community Health Q4 Earnings Miss on Lower Adjusted Admissions
by Zacks Equity Research
CYH expects 2025 capital expenditures to be in the range of $350-$4000 million.
Compared to Estimates, Community Health Systems (CYH) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Community Health Systems (CYH) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Community Health Systems (CYH) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of -940% and 3.32%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Can Community Health Beat Q4 Earnings on Growing Occupancy?
by Zacks Equity Research
CYH's fourth-quarter earnings are likely to have been aided by higher revenue per adjusted admission.
Community Health Systems (CYH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Community Health Systems (CYH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Generac to Report Q4 Earnings: Here's What Investors Should Know
by Zacks Equity Research
GNRC's fourth-quarter performance is likely to have gained from strength in the home standby generators category. Weakness in C&I sales remains concerning.
Mettler-Toledo Q4 Earnings Top Estimates, Sales Up Y/Y, Shares Rise
by Zacks Equity Research
MTD's fourth-quarter 2024 results reflect strong growth in the Laboratory business. However, softness in the Food Retail business reflects weaker demand.
Should Value Investors Buy Community Health Systems (CYH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Industry Outlook Highlights HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health
by Zacks Equity Research
HCA Healthcare, Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health have been highlighted in this Industry Outlook article.